Literature DB >> 23109726

Absence of CD59 exacerbates systemic autoimmunity in MRL/lpr mice.

Takashi Miwa1, Lin Zhou, Michael A Maldonado, Michael P Madaio, Robert A Eisenberg, Wen-Chao Song.   

Abstract

CD59 is a GPI-anchored membrane regulator of complement expressed on blood cells as well as peripheral tissues. It protects host cells from complement injury by inhibiting formation of the membrane attack complex. Recent studies in mice have suggested also a role of CD59 in T cell immune response that was mechanistically independent of complement. In the present study, we investigated the function of CD59 in the MRL/lpr model of murine lupus. We backcrossed the Cd59a knockout (Cd59a(-/-)) mouse onto the MRL/lpr background and compared Cd59a(+/+)-MRL/lpr and Cd59a(-/-)-MRL/lpr littermates for the development of systemic autoimmunity. We found that CD59a deficiency significantly exacerbated the skin disease and lymphoproliferation characteristic of MRL/lpr mice. It also increased autoantibody titers and caused a higher level of proteinuria in male MRL/lpr mice. Bone marrow transfer experiments indicated that CD59a expression on both bone marrow-derived cells and peripheral tissues played a role in lymphoproliferation, whereas the skin disease phenotype is determined mainly by local CD59a expression. Importantly, C3 gene deletion or C5 neutralization with a blocking mAb in Cd59a(-/-)-MRL/lpr mice did not rescue the proautoimmune phenotype associated with CD59a deficiency. These results together suggest that CD59a inhibits systemic autoimmunity in MRL/lpr mice through a complement-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23109726      PMCID: PMC3507618          DOI: 10.4049/jimmunol.1201621

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Sex differences in autoimmune disease.

Authors:  C C Whitacre
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

2.  Complement C4 is protective for lupus disease independent of C3.

Authors:  Shirit Einav; Olga O Pozdnyakova; Minghe Ma; Michael C Carroll
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

3.  Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.

Authors:  Takashi Miwa; Lin Zhou; Brendan Hilliard; Hector Molina; Wen-Chao Song
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

4.  Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison.

Authors:  Claire L Harris; S Melanie Hanna; Masashi Mizuno; Dewi S Holt; Kevin J Marchbank; B Paul Morgan
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

5.  Critical protection from renal ischemia reperfusion injury by CD55 and CD59.

Authors:  Koei Yamada; Takashi Miwa; Jianuo Liu; Masaomi Nangaku; Wen-Chao Song
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

6.  Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.

Authors:  Margaret K Elliott; Tambi Jarmi; Phil Ruiz; Yuanyuan Xu; V Michael Holers; Gary S Gilkeson
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

7.  Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset.

Authors:  H C Morse; W F Davidson; R A Yetter; E D Murphy; J B Roths; R L Coffman
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

8.  Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice.

Authors:  Takashi Miwa; Michael A Maldonado; Lin Zhou; Xiujun Sun; Hong Yuan Luo; Dewei Cai; Victoria P Werth; Michael P Madaio; Robert A Eisenberg; Wen-Chao Song
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

9.  Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.

Authors:  Hector Molina; Takashi Miwa; Lin Zhou; Brendan Hilliard; Dimitrios Mastellos; Michael A Maldonado; John D Lambris; Wen-Chao Song
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

Review 10.  The role of complement in the development of systemic lupus erythematosus.

Authors:  Anthony P Manderson; Marina Botto; Mark J Walport
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  6 in total

Review 1.  Complement in Lupus Nephritis: New Perspectives.

Authors:  Lihua Bao; Patrick N Cunningham; Richard J Quigg
Journal:  Kidney Dis (Basel)       Date:  2015-06-30

Review 2.  Autoimmunity in 2012.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

3.  The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon.

Authors:  John V Asimakopoulos; Evangelos Terpos; Loula Papageorgiou; Olga Kampouropoulou; Dimitris Christoulas; Anastasios Giakoumis; Michael Samarkos; George Vaiopoulos; Konstantinos Konstantopoulos; Maria K Angelopoulou; Theodoros P Vassilakopoulos; John Meletis
Journal:  Med Sci Monit       Date:  2014-01-27

Review 4.  Organization, evolution and functions of the human and mouse Ly6/uPAR family genes.

Authors:  Chelsea L Loughner; Elspeth A Bruford; Monica S McAndrews; Emili E Delp; Sudha Swamynathan; Shivalingappa K Swamynathan
Journal:  Hum Genomics       Date:  2016-04-21       Impact factor: 4.639

5.  The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus.

Authors:  Anne Troldborg; Lisbeth Jensen; Bent Deleuran; Kristian Stengaard-Pedersen; Steffen Thiel; Jens Christian Jensenius
Journal:  Front Immunol       Date:  2018-03-26       Impact factor: 7.561

6.  Monocyte Response to Different Campylobacter jejuni Lysates Involves Endoplasmic Reticulum Stress and the Lysosomal⁻Mitochondrial Axis: When Cell Death Is Better Than Cell Survival.

Authors:  Barbara Canonico; Gianna Di Sario; Erica Cesarini; Raffaella Campana; Francesca Luchetti; Loris Zamai; Claudio Ortolani; Maria Gemma Nasoni; Wally Baffone; Stefano Papa
Journal:  Toxins (Basel)       Date:  2018-06-13       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.